Testing A Visual Thermometer in Newborns and Young Infants

Sponsor
University of Minnesota (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05609292
Collaborator
(none)
120
2.9

Study Details

Study Description

Brief Summary

"Severe neonatal jaundice and acute bilirubin encephalopathy are a major cause of death and disability among newborns in LMICs. Filtered sunlight phototherapy (FSPT) was developed, tested and shown to be safe and efficacious in the treatment of jaundice, because effective electric-powered conventional phototherapy is often unavailable10,11. However, FSPT currently requires at least hourly temperature monitoring by healthcare providers (HCPs) because infants receiving FSPT are prone to both hypothermia and hyperthermia.

20 years ago, a liquid crystal thermometer, ThermospotTM (Maternova, Providence, RI) was developed primarily for use in LMICs. It was designed to detect hypothermia and is most sensitive in cold infants and not as sensitive as needed for detecting hyperthermia or fever. The purpose of this pilot study is to determine the accuracy and useability of this LCTD for a wider spectrum of temperatures when used in a large group of infants in a high-income country. If the device performs well in this study, we plan to study it in a low- and middle-income country in Africa."

Condition or Disease Intervention/Treatment Phase
  • Device: observational

Study Design

Study Type:
Observational
Anticipated Enrollment :
120 participants
Observational Model:
Case-Crossover
Time Perspective:
Prospective
Official Title:
Testing A Visual Thermometer in Newborns and Young Infants
Anticipated Study Start Date :
Dec 5, 2022
Anticipated Primary Completion Date :
Mar 3, 2023
Anticipated Study Completion Date :
Mar 3, 2023

Arms and Interventions

Arm Intervention/Treatment
Study group

Infants will get their temperature measured with the liquid crystal thermometer. We are not providing any interventions as they will be in the care of a healthcare team.

Device: observational
Infants will get their temperature measured with the liquid crystal thermometer. We are not providing any interventions as they will be in the care of a healthcare team.

Outcome Measures

Primary Outcome Measures

  1. Accuracy of the liquid crystal thermometer with measuring a temperature [baseline]

    determining the accuracy of the LCTD in estimating the temperature of infants 0-6 months presenting to the emergency room for treatment

  2. Parents/Caregivers and Healthcare provider accuracy in evaluating the infant temperature [baseline]

    Our secondary endpoint is determining parents/caregivers and healthcare provider accuracy in evaluating the temperature of their infant or the infant they are caring for and determining the category of the temperature.

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Months to 6 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Infants 0-6 months (<7 months) presenting to Masonic Emergency Room or inpatient ward, their parent or caregiver who provide verbal consent in English or through a medical interpreter.
Exclusion Criteria:
  • Any infant undergoing active resuscitation

  • any infant for whom physician deems study enrollment would interfere with their care

  • any infant whose parents or caregiver decline enrollment

  • any nurse or other healthcare provider who declines participation

  • Parents who do not understand English, and do not have a medical interpreter at the bedside.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Tina Slusher, MD, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT05609292
Other Study ID Numbers:
  • new
First Posted:
Nov 8, 2022
Last Update Posted:
Nov 8, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Minnesota
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 8, 2022